Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002127235 | SCV002403235 | benign | Tumor predisposition syndrome 3 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003382844 | SCV004091451 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-06-23 | criteria provided, single submitter | clinical testing | The c.703-3delT intronic variant is located 3 nucleotides before coding exon 6 of the POT1 gene. This variant results from a deletion of one nucleotide at position c.703-3. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |